PARAGON Study Confirms sustained Efficacy and Safety of NEUROMARK® System in Allergic and Nonallergic rhinitis Patients

GALWAY, Ireland, Oct.10, 2025 /PRNewswire/ — Neurent Medical, a company pioneering innovative non-surgical interventions to treat chronic inflammatory sinonasal diseases, today announced positive two-year results from the PARAGON clinical study, published in Ear, Nose, & Throat Journal.The data confirm that treatment wiht Neurent Medical’s NEUROMARK System, a radiofrequency ablation device indicated for chronic rhinitis, provides durable, clinically meaningful improvements in symptoms and quality of life for patients with both allergic and nonallergic rhinitis.

Key 2-Year Efficacy Findings